We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > Psychedelics

Psychedelics

Meet the Team Who Want To Develop Psychedelics Without the Hallucinations

Technology Networks – Analytical Cannabis’ sister publication – spoke to the team at Delix Therapeutics' to learn how their drugs can keep the benefits of psychedelics compounds while leaving behind the trip.

Read More

Analytical Cannabis Named ‘Unsung Hero’ by NewsGuard

The credibility watchdog praised Analytical Cannabis’ dedication to fact-based reporting of cannabis industry events and relevant scientific research.

Read More

Most Psychedelic Drug Users Believe in a Higher Power Following Their Trip, Study Finds

While these psychedelics users did tend to report an increased belief in the paranormal after their trip, superstitious beliefs largely remained unchained.

Read More

The Top 10 Cannabis Stories of 2022

Analytical Cannabis rounds up the year’s top cannabis stories, with a particular focus on research and testing.

Read More

Awakn Expands Its Ketamine Trial For Alcohol Use Disorder

The first-of-its-kind phase 3 trial will soon begin in the UK to test whether ketamine can help treat patients with alcohol use disorder.

Read More

Is Ayahuasca Safe? We Ask a Researcher

Dr. Perkins spoke with Technology Networks – the sister publication of Analytical Cannabis – to provide context on the latest research study and the next steps for the research group.

Read More

International Regulatory Developments For Key Psychedelics

Stephen Wright breaks down the lengthy process of getting a psychedelic medicine approved in the US.

Read More

Most Ayahuasca Users Vomit, Study Finds

Acute physical health adverse effects were reported by 69.9% of the study's participants.

Read More

The Dark Side of Psychedelic Trials

Dr. Markus Roggen, president and chief science officer of Vancouver-based Delic Labs, delves into the less favorable side of psychedelic research.

Read More

 
Advertisement